Drug Approval Process

Drug Approval Process concept illustrated in a photorealistic editorial healthcare scene.

Drug Approval Process Explainer

Before a new drug can be marketed in the United States, developers generally study it in the laboratory, test it in animals when appropriate, and ask the FDA for permission to begin human trials. Early clinical studies focus on safety and dosing, while later trials examine effectiveness and monitor harms in larger groups.

The sponsor then submits an application containing manufacturing information, proposed labeling, and data from nonclinical and clinical studies. FDA reviewers from several disciplines evaluate whether the evidence shows the drug is safe and effective for its proposed use and whether manufacturing can consistently meet quality standards.

Approval does not mean zero risk or certainty about every patient. It means the demonstrated benefits outweigh known and potential risks for the labeled use under the conditions studied. Some products use expedited programs when serious conditions or unmet needs justify a faster or different evidence pathway.

Safety monitoring continues after approval because uncommon or long-term effects may appear only when many more people use the drug. The FDA can require studies, update warnings, restrict use, inspect manufacturing, or take other action. Clinicians and patients also report suspected problems.

Phase 1 commonly examines safety, dose, and how the body handles the drug. Phase 2 explores effectiveness and side effects in people with the condition.

Phase 3 usually provides broader evidence for benefit and risk, while postmarket studies may be described as Phase 4.

Review teams assess clinical data, statistics, pharmacology, manufacturing controls, proposed labeling, and plans for managing risks.

Facilities and production processes may be inspected to determine whether quality requirements can be met consistently.

Approval applies to specific indications, populations, doses, and labeling supported by the evidence. It is not a guarantee of benefit for every individual.

New evidence can change recommendations and warnings. Patients should use medicines with guidance appropriate to their own conditions and other treatments.

Explore more "Explainers"

Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.